Even with early treatment, infants and toddlers with SMA have problems with swallowing skills compared with healthy children, ...

Columnist Brianna Albers hoped a new medicine would address several of her symptoms, but the side effects have left her skeptical.

Genentech has stopped developing emugrobart after trial results showed no consistent benefit when added to Evrysdi in people ...

In 2018, when Nell Choi was 9 years old, she began experiencing symptoms that led to hospitalization and a diagnosis of ...

Columnist Sherry Toh usually cringes at people who stare, but a performative art project taught her something new about ...

Up to three years of Evrysdi treatment appears safe and may help presymptomatic children with SMA reach and maintain key ...

The movement-related benefits of Itvisma were maintained or continued to deepen over about 15 months after treatment, trial ...

High doses of Spinraza may help stabilize or improve motor function for many people with SMA, per pooled clinical trial ...

Columnist Ari Anderson recently enjoyed six weeks free from searching for new members of his nursing staff. Now, he's aiming ...

As a licensed clinical social worker based in Amarillo, Texas, Ali Ramos uses her own experience of living with spinal muscular atrophy (SMA) type 2 to create a safe space for her clients to explore ...